German Serum and Vaccine Sector
A sector in the German economy that stood out to me was the serums and vaccines industry. The country is known for its efficient and developed healthcare system, as well as the quality pharmaceuticals that come from Germany. Standing at 1–2 percent of the German economy, this industry is one the most significant in not only the economy but also health-wise.
The Covid-19 pandemic has highlighted the influence of vaccines, bringing it to the forefront of public consciousness. In fact, the Pfizer-BioNTech vaccine was developed in collaboration between BioNtech, a German company, and Pfizer, an American company. This specific vaccine has been in use in numerous countries, including the United States, and it has been a major factor in the fight against the pandemic.
Other historical vaccines have also been produced in Germany. For example, serums and vaccines for a variety of diseases including polio, mumps, and measles. These vaccines are contemporarily used today around the world, and they have had a profound impact on public health. A specific example is the polio vaccine, developed in the 1950s by Jonas Salk, which essentially eradicated the disease.
An interesting comparison to note between Germany and the United States is public opinion of vaccines. According to Volker Witting from DW, vaccine reception and efficacy in Germany has long been politicized, similar to America with skepticism over whether vaccines actually are needed. In a political context, parties have been and still are ideologically divided as the Covid pandemic is just about over.
Looking ahead, the serums and vaccines sector will continue to be important in the German economy as novel diseases emerge and the need for vaccines and serums increases. Additionally, the sector likely will source innovation and growth, as entities develop new technologies and techniques for producing these products.
In conclusion, the serums and vaccines industry is a critically important sector in the German economy, both now and in the future. The sector’s history of producing high-quality products, its current success in developing COVID-19 vaccines, and its ongoing research and development efforts all contribute to its importance in the German economy. As new diseases pop up and the need for vaccines and serums also increases, the sector will continue to play a major role in public health and in the growth of the German economy.